Novartis (NVS) News Today

CreativeOne Wealth LLC purchased a new stake in shares of Novartis AG (NYSE:NVS - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,239 shares of the company's stock, valued at approximatel

Pitcairn Co. purchased a new position in Novartis AG (NYSE:NVS - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,108 shares of the company's stock, valued at approximately $881,000. Other hedge fun

O Shaughnessy Asset Management LLC lifted its holdings in Novartis AG (NYSE:NVS - Free Report) by 6.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 180,764 shares of the company's stock after purchasing an additional 11,080 shares during the pe

Novartis AG (NYSE:NVS - Get Free Report) has received a consensus recommendation of "Hold" from the seven brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have issued

Banco Santander S.A. reduced its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 9.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,469 shares of the company's stock after selling 6,180 shares duri

Novartis (NYSE:NVS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.10. Novartis had a return on equity of 32.15% and a net margin of 31.33%. During the same period in the previous year, the firm posted $1.83 earnings per share.

Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Novartis in a report on Friday.

Novartis released its Q2 financial results. It beat expectations on EPS and revenue. However, shares fell, possibly due to bad news on one upcoming drug.

Avantax Advisory Services Inc. boosted its holdings in Novartis AG (NYSE:NVS - Free Report) by 54.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,766 shares of the company's stock aft

Bleakley Financial Group LLC grew its holdings in Novartis AG (NYSE:NVS - Free Report) by 12.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 54,731 shares of the company's stock after purchasing an additional 5,903 shares du

Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.

Henry James International Management Inc. grew its position in Novartis AG (NYSE:NVS - Free Report) by 71.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,733 shares of the company's stock after purchasing an addi

Novartis AG (NYSE:NVS - Get Free Report) was the recipient of some unusual options trading on Thursday. Traders bought 5,026 put options on the stock. This is an increase of 99% compared to the average daily volume of 2,524 put options.

Quantbot Technologies LP grew its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 395.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 63,099 shares of the company's stock after acquiring a

Delaney Dennis R lessened its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 22.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,775 shares of the company's stock after selling 7,080 shares

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 47.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,727 shares of the company's stock afte

FORA Capital LLC bought a new stake in Novartis AG (NYSE:NVS - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 30,681 shares of the company's stock, valued at approximately $2,968,000. Other hedge funds an

Novartis (NYSE:NVS) Reaches New 12-Month High at $108.85

Sequoia Financial Advisors LLC lessened its stake in Novartis AG (NYSE:NVS - Free Report) by 35.3% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 25,311 shares of the company's stock after selling 13,796 shares during the quarter. Seq

Jefferies Financial Group increased their target price on shares of Novartis from $121.00 to $122.50 and gave the company a "buy" rating in a research report on Tuesday.

Scharf Investments LLC decreased its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 4.1% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,364,854 shares of the company's stock after selling 58,866 shares during the period. N